Balentine LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,072
Closed -$680K 210
2025
Q1
$680K Buy
+1,072
New +$737K 0.03% 92
2024
Q2
Sell
-3,278
Closed -$3.16M 479
2024
Q1
$3.16M Sell
3,278
-121
-4% -$115K 0.09% 70
2023
Q4
$2.99M Buy
3,399
+97
+3% +$79.9K 0.1% 75
2023
Q3
$2.72M Buy
3,302
+45
+1% +$35.4K 0.09% 68
2023
Q2
$2.34M Buy
3,257
+32
+1% +$24.7K 0.08% 75
2023
Q1
$2.65M Sell
3,225
-391
-11% -$295K 0.09% 78
2022
Q4
$2.61M Buy
3,616
+405
+13% +$299K 0.09% 80
2022
Q3
$2.21M Sell
3,211
-655
-17% -$412K 0.08% 72
2022
Q2
$2.29M Buy
3,866
+1,587
+70% +$1.03M 0.08% 96
2022
Q1
$1.59M Buy
2,279
+1,652
+263% +$1.05M 0.05% 105
2021
Q4
$396K Buy
627
+44
+8% +$27.1K 0.01% 202
2021
Q3
$353K Buy
+583
New +$362K 0.01% 161
2020
Q3
Sell
-99
Closed -$62K 695
2020
Q2
$62K Buy
99
+9
+10% +$5.11K ﹤0.01% 210
2020
Q1
$44K Buy
90
+86
+2,150% +$35.5K ﹤0.01% 191
2019
Q4
$2K Hold
4
﹤0.01% 543
2019
Q3
$1K Sell
4
-3
-43% -$888 ﹤0.01% 713
2019
Q2
$2K Buy
+7
New +$2.33K ﹤0.01% 645
2018
Q1
Sell
-31
Closed -$12K 420
2017
Q4
$12K Sell
31
-27
-47% -$10.9K ﹤0.01% 448
2017
Q3
$26K Hold
58
﹤0.01% 358
2017
Q2
$28K Hold
58
﹤0.01% 324
2017
Q1
$22K Buy
58
+31
+115% +$11.5K ﹤0.01% 331
2016
Q4
$10K Hold
27
﹤0.01% 409
2016
Q3
$11K Hold
27
﹤0.01% 350
2016
Q2
$9K Buy
+27
New +$10.4K ﹤0.01% 365
2016
Q1
Sell
-74
Closed -$40K 386
2015
Q4
$40K Buy
+74
New +$40.1K 0.01% 175

Other funds holding REGN